Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.525    0.05 (3.39%)
Bid:
1.45
Ask:
1.60
Spread: 0.15 (10.345%)
Market Cap: £13.14m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Grant of Options

19 Jan 2016 07:00

RNS Number : 2453M
Xeros Technology Group plc
19 January 2016
 

19 January 2016

Xeros Technology Group plc

("Xeros" or the "Group")

Grant of Options

Xeros Technology Group plc ("Xeros" or the "Company") (AIM: XSG), the innovative developer of patented polymer bead systems with multiple identified commercial applications, announces that on 18 January 2016 the Board of Xeros granted a total of 876,437 options over the Company's ordinary shares of 0.15 pence each ("Options"), representing 1.0% per cent of the issued share capital of the Company, to a Director and certain other employees of the Company. Details of the award to the Director are set out below:

Director

Role

Number of options granted

Chris Hanson

Chief Financial Officer and Company Secretary

125,000

 

All Options are exercisable at 182.5 pence per Ordinary Share, and are granted under the terms of Xeros' existing share option schemes.

Enquiries:

Xeros Technology Group plc Via Instinctif Partners

Mark Nichols, Chief Executive Officer

Chris Hanson, Chief Financial Officer

 

Jefferies International Limited (Nominated Adviser) Tel: 020 7029 8000

Simon Hardy / Harry Nicholas

 

Instinctif Partners (Financial PR)  Tel: 020 7457 2020

Helen Tarbet / James Gray

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLFFVILVITLIR
Date   Source Headline
1st Jul 20268:00 amRNSBlock Listing Six Monthly Return
10th Jun 20263:11 pmRNSResult of AGM
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.